FY2017 EPS Estimates for Molina Healthcare Inc. (MOH) Reduced by Leerink Swann
Molina Healthcare Inc. (NYSE:MOH) – Stock analysts at Leerink Swann lowered their FY2017 earnings per share (EPS) estimates for Molina Healthcare in a research note issued to investors on Wednesday. Leerink Swann analyst A. Gupte now anticipates that the brokerage will post earnings per share of $4.00 for the year, down from their previous estimate of $4.37. Leerink Swann currently has a “Buy” rating on the stock. Leerink Swann also issued estimates for Molina Healthcare’s FY2018 earnings at $5.09 EPS and FY2019 earnings at $6.24 EPS.
Molina Healthcare (NYSE:MOH) last issued its quarterly earnings data on Thursday, October 27th. The company reported $0.85 EPS for the quarter, topping the Zacks’ consensus estimate of $0.76 by $0.09. The firm earned $4.50 billion during the quarter, compared to the consensus estimate of $4.37 billion. Molina Healthcare had a return on equity of 9.38% and a net margin of 0.76%. The firm’s revenue was up 24.6% on a year-over-year basis. During the same period in the prior year, the business earned $0.89 EPS.
Several other brokerages also recently weighed in on MOH. Zacks Investment Research downgraded Molina Healthcare from a “buy” rating to a “hold” rating in a research note on Monday, October 3rd. Cantor Fitzgerald reiterated a “hold” rating and issued a $55.00 price objective on shares of Molina Healthcare in a research report on Friday, July 29th. Jefferies Group raised their price objective on Molina Healthcare from $63.00 to $70.00 and gave the stock a “buy” rating in a research report on Tuesday, September 13th. Goldman Sachs Group Inc. upgraded Molina Healthcare from a “sell” rating to a “neutral” rating and raised their price objective for the stock from $51.00 to $58.00 in a research report on Monday, September 19th. Finally, Credit Suisse Group AG downgraded Molina Healthcare from a “neutral” rating to an “underperform” rating and reduced their price objective for the stock from $63.00 to $47.00 in a research report on Friday. Two analysts have rated the stock with a sell rating, six have issued a hold rating and four have assigned a buy rating to the stock. Molina Healthcare presently has an average rating of “Hold” and a consensus price target of $61.70.
Shares of Molina Healthcare (NYSE:MOH) traded down 5.66% on Thursday, reaching $47.53. The company had a trading volume of 4,144,822 shares. Molina Healthcare has a 12 month low of $44.50 and a 12 month high of $67.87. The firm has a market capitalization of $2.70 billion, a PE ratio of 20.79 and a beta of 1.19. The company’s 50-day moving average is $56.40 and its 200 day moving average is $53.62.
In related news, Director Garrey Carruthers sold 1,600 shares of the firm’s stock in a transaction on Tuesday, September 13th. The stock was sold at an average price of $55.46, for a total transaction of $88,736.00. Following the completion of the sale, the director now directly owns 9,508 shares of the company’s stock, valued at approximately $527,313.68. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, COO Terry Bayer sold 7,825 shares of the firm’s stock in a transaction on Monday, October 24th. The shares were sold at an average price of $60.00, for a total value of $469,500.00. The disclosure for this sale can be found here. Corporate insiders own 6.89% of the company’s stock.
Large investors have recently added to or reduced their stakes in the stock. Epoch Investment Partners Inc. boosted its stake in Molina Healthcare by 26.6% in the third quarter. Epoch Investment Partners Inc. now owns 770,976 shares of the company’s stock worth $44,963,000 after buying an additional 161,767 shares in the last quarter. Pacer Advisors Inc. boosted its stake in Molina Healthcare by 4.2% in the third quarter. Pacer Advisors Inc. now owns 7,780 shares of the company’s stock worth $453,000 after buying an additional 312 shares in the last quarter. Bellevue Group AG acquired a new stake in Molina Healthcare during the third quarter worth $962,000. Principal Financial Group Inc. boosted its stake in Molina Healthcare by 8.0% in the third quarter. Principal Financial Group Inc. now owns 170,398 shares of the company’s stock worth $9,937,000 after buying an additional 12,629 shares in the last quarter. Finally, Northern Trust Corp boosted its stake in Molina Healthcare by 1.1% in the third quarter. Northern Trust Corp now owns 661,040 shares of the company’s stock worth $38,552,000 after buying an additional 7,466 shares in the last quarter. 88.10% of the stock is owned by hedge funds and other institutional investors.
About Molina Healthcare
Molina Healthcare, Inc offers Medicaid-related solutions for low-income families and individuals, and assists government agencies in their administration of the Medicaid program. The Company operates through three segments: Health Plans, Molina Medicaid Solutions and Other. Its Health Plans segment consists of health plans in approximately 10 states and the Commonwealth of Puerto Rico, and its direct delivery business.
Receive News & Stock Ratings for Molina Healthcare Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Molina Healthcare Inc. and related stocks with our FREE daily email newsletter.